Assessment of HCV-RNA test results and access rates to antiviral treatment in patients with anti-HCV positivity-a 10-year analysis

E Türkoğlu, Z Parlak, HŞ Barut - Turkish journal of medical …, 2022 - journals.tubitak.gov.tr
Background/aim: Currently, hepatitis C virus (HCV) infection can be cured by direct-acting
antivirals (DAAs). In this study, we aimed to find the rate of viremia among patients with a …

Treatment initiation rates of patients with positive anti-hepatitis C virus results in tertiary hospitals in Turkey

M Çelen, B Sengel, S Kaya, N Demirturk… - Journal of Infection …, 2024 - avesis.atauni.edu.tr
Introduction: The aim of this national, multicenter, cross-sectional, retrospective chart review
study was to determine the proportion of patients in Turkey who received hepatitis C virus …

[PDF][PDF] Üçüncü basamak kamu hastanesinde altı yıllık HCV seroprevalansı ve HCV RNA ile korelasyonunun değerlendirilmesi

P Şamlıoğlu, YK Derici, G Doğan… - J Tepecik Educ …, 2022 - jag.journalagent.com
Amaç: Hepatit C virüsü (HCV), kronik karaciğer hastalığı, siroz ve hepatoselüler
karsinomaya yol açabilmesi nedeniyle dünyada ve ülkemizde önemli bir halk sağlığı …

Anti-hcv bakılan olgularda hcv-rna sonuçlarının değerlendirilmesi

F Gönan - 2023 - acikerisim.erbakan.edu.tr
Özet Bu çalışmada anti-HCV pozitif olan hastalarda HCV-RNA istenme oranı ve pozitifliğinin
belirlenmesi, anti-HCV pozitifliği saptandıktan sonra HCV-RNA bakılmayan hastaların …

Treatment initiation rates of patients with positive anti-hepatitis C virus results in tertiary hospitals in Turkey: a retrospective, cross-sectional chart review (Lost-C Study)

MK Çelen, BE Şengel, Ş Kaya, N Demirtürk, A Azap… - 2022 - researchsquare.com
Background: The aim of this national, multicenter, cross-sectional, retrospective chart review
study was to determine the rate of patients in Turkey who received hepatitis C virus (HCV) …